The rapid expansion of private equity ownership within the United States healthcare sector has reached a critical juncture, as a comprehensive new report from the NYU Stern Center for Business and Human Rights warns that the current investment model is fundamentally at odds with the delivery of quality medical services. Released in March, the report underscores a growing pattern of hospital closures, depleted staffing levels, and compromised patient safety, suggesting that without immediate regulatory intervention and industry self-reform, the healthcare infrastructure for millions of Americans remains at risk. The findings highlight a systemic disconnect between the high-speed, debt-heavy financial goals of private equity firms and the long-term, high-stakes requirements of clinical care.
The Magnitude of Private Equity’s Healthcare Footprint
Over the last decade, private equity (PE) firms have fundamentally reshaped the landscape of American medicine. According to the NYU Stern analysis, these firms have poured more than $1 trillion into healthcare deals, largely financed through significant debt. This influx of capital has touched nearly every corner of the industry, from multi-state hospital systems and specialty physician practices to nursing homes, hospice care, and emergency medical services.
The motivation for this investment surge is often rooted in the search for "recession-proof" assets that provide steady cash flows. However, the report argues that the specific mechanics of the private equity model—characterized by short-term holding periods (typically three to seven years), aggressive cost-cutting, and high leverage—create a volatile environment for facilities that require stable, long-term investment. While PE firms often claim to bring operational efficiencies and necessary capital to struggling facilities, the research suggests that the cost of these efficiencies is frequently borne by patients and frontline medical staff.
Analyzing the Human Cost: Complications and Mortality Rates
The NYU Stern report synthesizes a wide array of peer-reviewed health outcomes research to paint a sobering picture of the clinical impact of private equity ownership. One of the most striking findings is the correlation between PE buyouts and a decline in patient safety. Research cited in the report indicates that in-hospital complications increase by an average of 25% following a private equity takeover. These complications often include falls, healthcare-associated infections, and surgical errors, which critics attribute to reduced oversight and a focus on throughput over thoroughness.
Staffing levels, a primary driver of patient outcomes, are often the first target for cost-reduction strategies. The report notes that nursing staff levels typically drop by 4.4% under private equity management. This reduction in the "bedside" workforce creates a ripple effect, leading to clinician burnout and decreased time for patient monitoring. The impact is perhaps most visible in the long-term care sector. The analysis found that private equity ownership of nursing homes is associated with an 11% increase in patient mortality rates. In these environments, where residents are highly vulnerable and require consistent, high-touch care, the "lean" staffing models favored by PE firms can have life-ending consequences.
Financial Instability and the Bankruptcy Epidemic
Beyond the clinical risks, the NYU Stern report highlights a profound threat to the financial viability of healthcare institutions. The use of leveraged buyouts—where the debt used to purchase a company is placed on the company’s own balance sheet—leaves healthcare providers with little room for error. The research shows that private equity ownership increases the risk of bankruptcy by a factor of ten.
The year 2023 served as a watershed moment for this trend, witnessing 34 bankruptcies of private equity-backed healthcare businesses. This financial instability is not a localized issue but a systemic one. When a PE-backed health system fails, it often leaves entire regions without essential services. The report specifically examines the trajectories of Steward Health Care and Prospect Medical Holdings as cautionary tales of this phenomenon.
Case Study: Steward Health Care
Steward Health Care was owned by the private equity firm Cerberus Capital Management from 2010 to 2021. During this tenure, the system engaged in several "sale-leaseback" transactions, selling the land underneath its hospitals to real estate investment trusts (REITs) to generate immediate cash for investors. However, this left the hospitals burdened with massive monthly rent payments. Following its transition from Cerberus, the system’s financial health continued to deteriorate, culminating in a high-profile bankruptcy in 2024. The fallout has led to the closure of several facilities, leaving low-income and rural populations in Massachusetts and other states with diminished access to emergency care.
Case Study: Prospect Medical Holdings
Similarly, Prospect Medical Holdings was owned by Leonard Green & Company between 2010 and 2021. Like Steward, Prospect faced immense financial pressure following its period of private equity ownership, eventually leading to a bankruptcy filing in 2025. The report notes that these failures are not merely business losses; they represent the collapse of essential social infrastructure. In many cases, the communities most affected are those that already face significant healthcare disparities.
A Fundamental Mismatch of Values
Michael Goldhaber, the author of the NYU Stern report, describes the relationship between private equity and healthcare as an "unhealthy fit." In an interview regarding the findings, Goldhaber emphasized the clash between the PE business model and the ethical imperatives of medicine.
"On the one side, you have a business model that is based on public anonymity, legal immunity, remote and financialized ownership and a lack of self-restraining norms," Goldhaber stated. "On the other side, you have a sector where all the stakes are life and death."
This "legal immunity" refers to the complex corporate structures often employed by PE firms, which can shield the parent company and its executives from malpractice lawsuits or regulatory fines incurred by the healthcare facilities they own. This lack of accountability, Goldhaber argues, removes the natural incentive for owners to prioritize patient safety over short-term dividends.
The Path Forward: Recommendations for Self-Reform
Despite the critical tone of the report, it does not call for an outright ban on private equity in the healthcare space. Goldhaber acknowledges that private equity can provide vital capital for modernization and technological integration that many independent or non-profit systems struggle to secure. Instead, the report advocates for a "fundamental adaptation" of the PE model to suit the unique requirements of the healthcare sector.
To avoid the looming threat of more stringent government oversight, the report suggests that private equity firms should engage in self-reform. Recommended measures for investors include:
- Equity-Heavy Investment: Reducing the reliance on high-interest debt and leveraged buyouts to ensure the target healthcare facility remains financially stable.
- Transparency and Disclosure: Moving away from "public anonymity" by providing clear data on ownership structures, staffing changes, and patient outcomes.
- Long-Term Commitment: Extending investment horizons beyond the typical five-year exit strategy to allow for sustainable growth and clinical improvements.
- Clinical Autonomy: Ensuring that medical decisions remain in the hands of healthcare professionals rather than being dictated by financial managers.
The Role of Government Regulation
While self-regulation is a preferred first step for industry insiders, the NYU Stern report concludes that government intervention is likely necessary to protect public health. The report provides a roadmap for state and federal regulators to curb the most predatory practices of the industry.
Key regulatory recommendations include:
- Enhanced Transparency Requirements: Mandating that PE firms disclose their ownership stakes in healthcare entities to help regulators and patients understand who is ultimately responsible for care.
- Liability Expansion: Amending laws to ensure that private equity owners can be held legally and financially accountable for systemic failures or medical negligence within their portfolio companies.
- Strengthened Merger Review: Empowering agencies like the Federal Trade Commission (FTC) and state attorneys general to scrutinize healthcare acquisitions more closely, particularly those that might lead to a monopoly in a specific geographic area or medical specialty.
- Limits on Dividend Recapitalization: Restricting the practice of firms taking out new debt against a healthcare company specifically to pay out dividends to investors, a practice that often leaves the facility in a precarious financial position.
Broader Implications and Industry Reactions
The release of the NYU Stern report comes at a time of heightened political interest in healthcare consolidation. In Washington, lawmakers have introduced various pieces of legislation, such as the "Health Over Profits Act," which seeks to increase oversight of private equity in the medical sector. Advocacy groups for nurses and patients have also voiced support for the report’s findings, arguing that the "financialization" of medicine has led to a measurable decline in the quality of the American workplace for healthcare professionals.
Industry groups representing private equity, such as the American Investment Council, have historically argued that PE firms save failing hospitals and provide the capital necessary for innovation. However, the sheer volume of data regarding staffing cuts and increased mortality rates in the NYU Stern report presents a significant challenge to that narrative.
As the healthcare industry continues to grapple with rising costs and an aging population, the debate over private equity’s role is likely to intensify. The NYU Stern report serves as a stark reminder that when the drive for profit supersedes the duty of care, the consequences are measured not just in dollars, but in human lives. The findings suggest that the "unhealthy fit" between private equity and healthcare will require more than just minor adjustments; it will require a complete reimagining of how capital serves the public good in the medical arena.
